THE 60-SECOND GUIDE
Sermorelin
Historical approved uses; current products require separate evaluation.
Guide prepared November 13, 2026 · profile review dates retained
What is it?
Sermorelin is a synthetic fragment of growth-hormone-releasing hormone that can stimulate pituitary growth-hormone secretion. It has a history of approved diagnostic and pediatric uses, but that history does not establish contemporary wellness claims. [1]
Potential benefits
Mimics the first 29 amino acids of GHRH. Can stimulate pituitary growth-hormone release. [1]
Evidence & its limits
The 2013 determination explains why historical products left the market; it does not newly approve a present-day compounded product. Diagnostic hormone responses and pediatric growth outcomes cannot, by themselves, demonstrate anti-aging or body-composition benefits in adults. [1]
Risks & unknowns
Geref approvals were withdrawn effective June 18, 2009. In 2013 FDA determined the products were not withdrawn for safety or effectiveness reasons. Contemporary wellness claims are not established by its historical diagnostic and pediatric growth-failure indications. [1]
Status & scope
It has a history of approved diagnostic and pediatric uses, but that history does not establish contemporary wellness claims. Geref approvals were withdrawn effective June 18, 2009. In 2013 FDA determined the products were not withdrawn for safety or effectiveness reasons. [1]
The question to ask
Does the evidence match the exact product, route, condition and outcome being discussed? Check the full record and its review dates. This summary is selective; the product label and clinical assessment contain additional warnings and contraindications.
CHECK THE RECORD
Sources & review
- Full evidence record, references and review dates
- FDA determination on withdrawn Geref products, March 4, 2013
Guide prepared November 13, 2026 · profile review dates retained. Condensed from the linked site evidence record. This format update is not a new clinical review of every source. Consult the full profile for its evidence-review dates and targeted updates.
Selective educational summary, not treatment or dosing advice. Existing profile review dates retained; no independent clinical review.